49 false false false false false false false false false false true false false false false false false No description of principal activity 2022-05-01 Sage Accounts Production Advanced 2023 - FRS102_2023 xbrli:pure xbrli:shares iso4217:GBP 08035795 2022-05-01 2023-10-31 08035795 2023-10-31 08035795 2022-04-30 08035795 2021-05-01 2022-04-30 08035795 2022-04-30 08035795 2021-04-30 08035795 core:FurnitureFittings 2022-05-01 2023-10-31 08035795 core:MotorVehicles 2022-05-01 2023-10-31 08035795 bus:LeadAgentIfApplicable 2022-05-01 2023-10-31 08035795 bus:Director1 2022-05-01 2023-10-31 08035795 core:WithinOneYear 2023-10-31 08035795 core:WithinOneYear 2022-04-30 08035795 core:AfterOneYear 2023-10-31 08035795 core:AfterOneYear 2022-04-30 08035795 core:ShareCapital 2023-10-31 08035795 core:ShareCapital 2022-04-30 08035795 core:RetainedEarningsAccumulatedLosses 2023-10-31 08035795 core:RetainedEarningsAccumulatedLosses 2022-04-30 08035795 bus:SmallEntities 2022-05-01 2023-10-31 08035795 bus:AuditExemptWithAccountantsReport 2022-05-01 2023-10-31 08035795 bus:SmallCompaniesRegimeForAccounts 2022-05-01 2023-10-31 08035795 bus:PrivateLimitedCompanyLtd 2022-05-01 2023-10-31 08035795 bus:AbridgedAccounts 2022-05-01 2023-10-31 08035795 core:ComputerEquipment 2022-05-01 2023-10-31
STATEMENT OF CONSENT TO PREPARE ABRIDGED FINANCIAL STATEMENTS
All of the members of Zanta Healthcare Limited have consented to the preparation of the abridged statement of income and retained earnings and the abridged statement of financial position for the period ending 31 October 2023 in accordance with Section 444(2A) of the Companies Act 2006.
COMPANY REGISTRATION NUMBER: 08035795
ZANTA HEALTHCARE LIMITED
FILLETED UNAUDITED ABRIDGED FINANCIAL STATEMENTS
FOR THE PERIOD ENDED
31 October 2023
ZANTA HEALTHCARE LIMITED
REPORT TO THE DIRECTOR ON THE PREPARATION OF THE UNAUDITED STATUTORY ABRIDGED FINANCIAL STATEMENTS OF ZANTA HEALTHCARE LIMITED
PERIOD FROM 1 MAY 2022 TO 31 OCTOBER 2023
In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the abridged financial statements of Zanta Healthcare Limited for the period ended 31 October 2023, which comprise the abridged statement of financial position and the related notes from the company's accounting records and from information and explanations you have given us. As a practising member firm of the Association of Chartered Certified Accountants, we are subject to its ethical and other professional requirements which are detailed at www.accaglobal.com/en/member/professional-standards/rules-standards/acca-rulebook.html. Our work has been undertaken in accordance with the requirements of the Association of Chartered Certified Accountants as detailed at www.accaglobal.com/content/dam/ACCA_Global/Technical/fact/technical-factsheet-163.pdf.
LANGARD LIFFORD HALL LIMITED Accountants and Registered Auditors
Lifford Hall Lifford Lane Kings Norton Birmingham B30 3JN
24 July 2024
ZANTA HEALTHCARE LIMITED
ABRIDGED STATEMENT OF FINANCIAL POSITION
31 October 2023
31 Oct 23
30 Apr 22
Note
£
£
£
£
Fixed assets
Tangible assets
5
19,732
7,939
Current assets
Debtors
164,613
256,177
Cash at bank and in hand
181,750
39,860
------------
------------
346,363
296,037
Creditors: amounts falling due within one year
135,260
101,480
------------
------------
Net current assets
211,103
194,557
------------
------------
Total assets less current liabilities
230,835
202,496
Creditors: amounts falling due after more than one year
6,156
12,194
------------
------------
Net assets
224,679
190,302
------------
------------
Capital and reserves
Called up share capital
50
50
Profit and loss account
224,629
190,252
------------
------------
Shareholders funds
224,679
190,302
------------
------------
These abridged financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
In accordance with section 444 of the Companies Act 2006, the abridged statement of income and retained earnings has not been delivered.
For the period ending 31 October 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Director's responsibilities:
- The members have not required the company to obtain an audit of its abridged financial statements for the period in question in accordance with section 476 ;
- The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of abridged financial statements .
ZANTA HEALTHCARE LIMITED
ABRIDGED STATEMENT OF FINANCIAL POSITION (continued)
31 October 2023
These abridged financial statements were approved by the board of directors and authorised for issue on 24 July 2024 , and are signed on behalf of the board by:
M Mhonyera
Director
Company registration number: 08035795
ZANTA HEALTHCARE LIMITED
NOTES TO THE ABRIDGED FINANCIAL STATEMENTS
PERIOD FROM 1 MAY 2022 TO 31 OCTOBER 2023
1. General Information
The company is a private company limited by shares, registered in England and Wales. The address of the registered office is Savoy Centre, Unit 4, Northfield Road, Netherton, Dudley, DY2 9ES.
2. Statement of Compliance
These abridged financial statements have been prepared in compliance with Section 1A of FRS 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland'.
3. Accounting Policies
Basis of preparation
The abridged financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss.
The abridged financial statements are prepared in sterling, which is the functional currency of the entity.
Judgements and key sources of estimation uncertainty
The preparation of the financial statements requires management to make judgements, estimates and assumptions that affect the amounts reported. These estimates and judgements are continually reviewed and are based on experience and other factors, including expectations of future events that are believed to be reasonable under the circumstances.
Revenue recognition
Turnover is measured at the fair value of the consideration received or receivable and represents amounts receivable for goods supplied and services rendered, stated net of discounts and of Value Added Tax.
Income tax
The taxation expense represents the aggregate amount of current and deferred tax recognised in the reporting period. Tax is recognised in profit or loss, except to the extent that it relates to items recognised in other comprehensive income or directly in equity. In this case, tax is recognised in other comprehensive income or directly in equity, respectively.
Tangible assets
Tangible assets are initially recorded at cost, and subsequently stated at cost less any accumulated depreciation and impairment losses. Any tangible assets carried at revalued amounts are recorded at the fair value at the date of revaluation less any subsequent accumulated depreciation and subsequent accumulated impairment losses.
Depreciation
Depreciation is calculated so as to write off the cost or valuation of an asset, less its residual value, over the useful economic life of that asset as follows:
Fixtures and fittings
-
15% reducing balance
Motor vehicles
-
20% reducing balance
Computer & IT equipment
-
25% straight line
Impairment of fixed assets
A review for indicators of impairment is carried out at each reporting date, with the recoverable amount being estimated where such indicators exist. Where the carrying value exceeds the recoverable amount, the asset is impaired accordingly. Prior impairments are also reviewed for possible reversal at each reporting date.
Government grants
Government grants are recognised at the fair value of the asset received or receivable. Grants are not recognised until there is reasonable assurance that the company will comply with the conditions attaching to them and the grants will be received. Government grants are recognised using the accrual model and the performance model. Under the accrual model, government grants relating to revenue are recognised on a systematic basis over the periods in which the company recognises the related costs for which the grant is intended to compensate. Grants that are receivable as compensation for expenses or losses already incurred or for the purpose of giving immediate financial support to the entity with no future related costs are recognised in income in the period in which it becomes receivable. Grants relating to assets are recognised in income on a systematic basis over the expected useful life of the asset. Where part of a grant relating to an asset is deferred, it is recognised as deferred income and not deducted from the carrying amount of the asset. Under the performance model, where the grant does not impose specified future performance-related conditions on the recipient, it is recognised in income when the grant proceeds are received or receivable. Where the grant does impose specified future performance-related conditions on the recipient, it is recognised in income only when the performance-related conditions have been met. Where grants received are prior to satisfying the revenue recognition criteria, they are recognised as a liability.
Financial instruments
A financial asset or a financial liability is recognised only when the entity becomes a party to the contractual provisions of the instrument. Basic financial instruments are initially recognised at the transaction price, unless the arrangement constitutes a financing transaction, where it is recognised at the present value of the future payments discounted at a market rate of interest for a similar debt instrument.
Defined contribution plans
Contributions to defined contribution plans are recognised as an expense in the period in which the related service is provided. Prepaid contributions are recognised as an asset to the extent that the prepayment will lead to a reduction in future payments or a cash refund.
4. Employee Numbers
The average number of persons employed by the company during the period amounted to 49 (2022: 49 ).
5. Tangible Assets
£
Cost
At 1 May 2022
12,513
Additions
18,475
------------
At 31 October 2023
30,988
------------
Depreciation
At 1 May 2022
4,574
Charge for the period
6,682
------------
At 31 October 2023
11,256
------------
Carrying amount
At 31 October 2023
19,732
------------
At 30 April 2022
7,939
------------
6. Director's Advances, Credits and Guarantees
Amounts owed to the director at the balance sheet date are included in creditors and totalled £671 (2022: £433).
7. Related Party Transactions
At the balance sheet date the company was owed £nil (2022 £45,417) by Hudson Housing Limited, a company under common control. An inter-company balance of £206,255 was agreed to be written off against a debt from this company during the period, showing as other income in the accounts. At the balance sheet date the company was owed £nil (2022 £100,000) by Tulsa Greenwood Investments Limited, a company under common control. An inter-company balance of £206,255 was agreed to be written off against a debt from this company during the period, showing as other income in the accounts.